TNFRSF12A and breast carcinoma: Rb-loss reduces several ‘hallmarks’ of immune response in mouse models, and its deficiency correlates with the induction of PVR, CD274 and several other IC modulators, including ICOSLG and TNFRSF12A in human breast cancer.